Table 1 Characteristics of study in patients with and without ABPM

Age, years

56.52 ± 13.72

49.32 ± 12.52

< 0.001

  ~ 29

3,317 (2.80)

1,860 (6.62)

< 0.001

 30 ~ 39

8,609 (7.26)

3,767 (13.40)

 40 ~ 49

22,315 (18.82)

7,882 (28.03)

 50 ~ 59

37,249 (31.41)

9,080 (32.29)

 60 ~ 69

25,993 (21.92)

4,088 (14.54)

 70 ~ 79

15,308 (12.91)

1,292 (4.60)

 80 ~ 

5,803 (4.89)

147 (0.52)

Female sex

54,709 (46.13)

12,266 (46.63)

< 0.001

Comorbidities

 Diabetes mellitus

14,550 (12.27)

3,530 (12.56)

0.192

 Dyslipidemia

22,491 (18.96)

8,650 (30.77)

< 0.001

 Chronic kidney disease

269 (0.23)

62 (0.22)

0.896

 Atrial fibrillation

555 (0.47)

191 (0.68)

< 0.001

 Ischemic heart disease

3,811 (3.21)

1,585 (5.64)

< 0.001

 Myocardial infarction

251 (0.21)

56 (0.21)

1.000

 Heart failure

556 (0.47)

130 (0.46)

0.925

 Ischemic stroke

2,683 (2.26)

427 (1.52)

< 0.001

 Intracranial hemorrhage

315 (0.27)

51 (0.18)

0.013

 Transient ischemic attack

1,238 (1.04)

253 (0.90)

0.033

Concomitant medications

 Anti-platelets

6,842 (5.77)

1,249 (4.44)

< 0.001

 Anti-diabetics

8,078 (6.81)

841 (2.99)

< 0.001

 Statins

9,746 (8.22)

2,164 (7.70)

0.004